Nurilla, Wadzna S.
HRN: 10-92-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2025
CEFUROXIME 500MG (TAB)
06/14/2025
06/21/2025
PO
500MG
BID
S/P PRIMARY LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes